0
0

Cataract Surgery Devices – Medical Devices Pipeline Assessment, 2019

Cataract Surgery Devices removes the natural lens of the eye that has developed an opacification and is then replacing it with an artificial intraocular lens to restore transparency. GlobalData's Medical Devices sector report, “Cataract Surgery Devices – Medical Devices Pipeline Assessment, 2019" provides comprehensive information about the Cataract Surgery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Cataract Surgery Devices Pipeline Assessment report provides key information and data related to:

Extensive coverage of the Cataract Surgery Devices under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Cataract Surgery Devices pipeline products.

Review of Recent Developments in the segment / industry

The Cataract Surgery Devices Pipeline Assessment report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Cataract Surgery Devices under development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2009 and forecast to 2023

• 4,500+ industry-leading analysis and procedure reports covering growing sectors, market trends, investment opportunities and competitive landscape

• 56,000+ medical equipment company profiles

• 4,300+ company profiles of medical equipment manufacturers in China and India

• 2,000+ company profiles of medical equipment manufacturers in Japan

• 825+ companies’ revenue splits and market shares

• 1,900+ quarterly and annual medical equipment company financials

• 940+ medical equipment company SWOTs

• 21,500+ pipeline product profiles

• 34,500+ marketed product profiles

• 36,000+ clinical trials

• 36,500+ trial investigators

• 5,400+ reports on companies with products in development

• 33,000+ deals in the medical equipment industry

• 1,300+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Cataract Surgery Devices under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Cataract Surgery Devices and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Cataract Surgery Devices under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies mentioned

Advanced Refractive Technologies Inc

Altacor Ltd

Bausch & Lomb Inc

Cirle, Inc

Dutch Ophthalmic Research Center International BV

Eye Care and Cure

Hebrew University of Jerusalem

Iantech Inc

International BioMedical Devices Inc

Medicontur Medical Engineering Ltd

Mynosys Cellular Devices, Inc.

OptoLight Vision Technology

Paradigm Medical Industries, Inc. (Inactive)

Shanghai Haohai Biological Technology Co Ltd

STAAR Surgical Company

Tear Diagno LLC (Inactive)

University of California Los Angeles

University of Florida

University of Michigan

University of Texas Medical Branch at Galveston

VSY Biotechnology BV

Wake Forest Baptist Medical Center

Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 7

2 Introduction 8

2.1 Cataract Surgery Devices Overview 8

3 Products under Development 9

3.1 Cataract Surgery Devices – Pipeline Products by Stage of Development 9

3.2 Cataract Surgery Devices – Pipeline Products by Segment 10

3.3 Cataract Surgery Devices – Pipeline Products by Territory 11

3.4 Cataract Surgery Devices – Pipeline Products by Regulatory Path 12

3.5 Cataract Surgery Devices – Pipeline Products by Estimated Approval Date 13

3.6 Cataract Surgery Devices – Ongoing Clinical Trials 14

4 Cataract Surgery Devices – Pipeline Products under Development by Companies 15

4.1 Cataract Surgery Devices Companies – Pipeline Products by Stage of Development 15

4.2 Cataract Surgery Devices – Pipeline Products by Stage of Development 16

5 Cataract Surgery Devices Companies and Product Overview 17

5.1 Advanced Refractive Technologies Inc Company Overview 17

5.1.1 Advanced Refractive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 17

5.2 Altacor Ltd Company Overview 18

5.2.1 Altacor Ltd Pipeline Products & Ongoing Clinical Trials Overview 18

5.3 Bausch & Lomb Inc Company Overview 19

5.3.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 19

5.4 Cirle, Inc Company Overview 26

5.4.1 Cirle, Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.5 Dutch Ophthalmic Research Center International BV Company Overview 27

5.5.1 Dutch Ophthalmic Research Center International BV Pipeline Products & Ongoing Clinical Trials Overview 27

5.6 Eye Care and Cure Company Overview 28

5.6.1 Eye Care and Cure Pipeline Products & Ongoing Clinical Trials Overview 28

5.7 Hebrew University of Jerusalem Company Overview 29

5.7.1 Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 29

5.8 Iantech Inc Company Overview 30

5.8.1 Iantech Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.9 International BioMedical Devices Inc Company Overview 31

5.9.1 International BioMedical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 31

5.10 Medicontur Medical Engineering Ltd Company Overview 32

5.10.1 Medicontur Medical Engineering Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

5.11 Mynosys Cellular Devices, Inc. Company Overview 33

5.11.1 Mynosys Cellular Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33

5.12 OptoLight Vision Technology Company Overview 35

5.12.1 OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview 35

5.13 Paradigm Medical Industries, Inc. (Inactive) Company Overview 38

5.13.1 Paradigm Medical Industries, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 38

5.14 Shanghai Haohai Biological Technology Co Ltd Company Overview 39

5.14.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

5.15 STAAR Surgical Company Company Overview 40

5.15.1 STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview 40

5.16 Tear Diagno LLC (Inactive) Company Overview 41

5.16.1 Tear Diagno LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 41

5.17 University of California Los Angeles Company Overview 42

5.17.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 42

5.18 University of Florida Company Overview 43

5.18.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 43

5.19 University of Michigan Company Overview 44

5.19.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 44

5.20 University of Texas Medical Branch at Galveston Company Overview 45

5.20.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 45

5.21 VSY Biotechnology BV Company Overview 46

5.21.1 VSY Biotechnology BV Pipeline Products & Ongoing Clinical Trials Overview 46

5.22 Wake Forest Baptist Medical Center Company Overview 47

5.22.1 Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 47

6 Cataract Surgery Devices- Recent Developments 48

6.1 Nov 20, 2019: Baring Private Equity Asia signs agreement to buy Lumenis 48

6.2 Nov 19, 2019: Alcon reports third quarter and nine months 2019 results 48

6.3 Nov 12, 2019: Ocular Therapeutix reports third quarter 2019 financial results and business update 51

6.4 Nov 06, 2019: Glaukos Corporation announces third quarter 2019 financial results 53

6.5 Nov 04, 2019: Bausch Health Companies announces third-quarter 2019 results and raises full-year revenue and adjusted EBITDA (non-GAAP) guidance ranges 54

6.6 Oct 30, 2019: STAAR surgical reports third quarter results for the year 2019 55

6.7 Oct 24, 2019: Anika reports third quarter 2019 financial results 57

6.8 Oct 14, 2019: Anika appoints Mira Leiwant as vice president of regulatory affairs, quality, and clinical affairs 58

6.9 Oct 09, 2019: Mynosys Cellular Devices secures $25 Million investment from decheng capital; names veteran ophthalmic executive Rob Thornhill as CEO 59

6.10 Oct 07, 2019: DORC obtains 510k clearance for launch of the EVA UPGRADED enhancements in the USA 59

6.11 Sep 21, 2019: EnFocus OCT fully integrated into the Proveo 8 microscope 60

6.12 Sep 14, 2019: ZEISS to showcase advancements in digital and surgical technology at ESCRS 2019 61

6.13 Sep 13, 2019: Alcon focuses on efficiency and minimally invasive cataract technologies in the operating room at ESCRS 2019 63

6.14 Sep 09, 2019: Alcon Launches LASIK innovations with new planning software and patient interface for the WaveLight Refractive Suite 64

6.15 Sep 03, 2019: EyeSouth establishes presence in Louisiana through affiliation with Eyecare Associates and Scott D. Lanoux & MD & Associates 65

6.16 Aug 20, 2019: Alcon reports second quarter and first half 2019 results 65

6.17 Aug 07, 2019: Ocular Therapeutix reports second quarter 2019 financial results and business update 67

6.18 Aug 07, 2019: Glaukos announces second quarter 2019 financial results 69

6.19 Aug 06, 2019: Bausch Health Companies announces second-quarter 2019 results and raises full-year guidance 70

6.20 Jul 31, 2019: STAAR Surgical reports record second quarter results for total revenue, ICL sales and ICL units 72

6.21 Jul 29, 2019: Bausch Health to reduce debt by additional $100 million using cash flow from operations 74

6.22 Jul 24, 2019: Anika reports second quarter 2019 financial results 74

6.23 Jul 11, 2019: Ocular Therapeutix announces Christopher White as Senior Vice President, Head of Business and Corporate Development 75

6.24 Jul 09, 2019: Ocular Therapeutix announces Patricia Kitchen as Chief Operations Officer 76

6.25 Jul 08, 2019: Anika appoints James Loerop as executive vice president of business development and strategic planning 76

6.26 Jul 01, 2019: Introducing Nanex Multisert+ the latest innovation from Hoya. A newly designed intraocular lens (iol) delivered in a first-of-its kind preloaded delivery system 77

6.27 May 30, 2019: Aequus to clarify press release of 23rd May 2019 relating to Zepto Capsulotomy System and Kensington Eye Institute 77

6.28 May 23, 2019: Aequus to supply Kensington Eye Institute with Zepto Capsulotomy system; Extends Distribution Agreement with Mynosys 78

6.29 May 15, 2019: Alcon reports first quarter 2019 trading update 78

6.30 May 10, 2019: Ocular Therapeutix reports first quarter 2019 financial results and business update 79

6.31 May 09, 2019: Santen reports fiscal 2018 consolidated performance 81

6.32 May 08, 2019: Glaukos announces first quarter 2019 financial results 81

6.33 May 06, 2019: Alcon launches advancements to the CENTURION Vision System at American Society for Cataract and Refractive Surgery Meeting 82

6.34 May 06, 2019: Bausch Health Companies announces first-quarter 2019 results and raises full-year guidance 83

6.35 May 06, 2019: Continued profitable growth for Carl Zeiss Meditec 86

6.36 May 06, 2019: Carl Zeiss Meditec: First half year 2018/2019 87

6.37 May 04, 2019: ZEISS announces new breakthroughs in digital technology and industry-first high-resolution imaging exclusively at ASCRS 88

6.38 May 02, 2019: Ophtec RingJect gets U.S. marketing approval 89

6.39 May 02, 2019: Anika reports first quarter 2019 financial results 89

6.40 May 01, 2019: Alcon to showcase new clinical data, innovative technology at American Society of Cataract and Refractive Surgery 2019 Annual Meeting 90

6.41 May 01, 2019: STAAR Surgical reports first quarter results 93

6.42 Apr 30, 2019: Anika Therapeutics names Stephen Goldy as vice president of U.S. Sales 94

6.43 Apr 29, 2019: Bausch + Lomb announces new scientific analyses featuring surgical and pharmaceutical products will be presented during The Annual Meeting Of The American Society Of Cataract And Refractive Surgery 95

6.44 Apr 29, 2019: Bausch + lomb invites surgeons to new in-booth experience exchange, events and scientific presentations during the annual meeting of the Annual Meeting of the American Society of Cataract and Refractive Surgery 97

6.45 Apr 26, 2019: Bausch + Lomb presents on Stellaris Elite Vision Enhancement System during The Association For Research In Vision And Ophthalmology Meeting 100

6.46 Apr 23, 2019: Ocular Therapeutix reports changes to board of directors 101

6.47 Apr 18, 2019: IQ Laser Vision brings 20/20 eyesight to California's Inland Empire with advanced Zeiss ReLEx SMILE technology 102

6.48 Apr 15, 2019: Eliminating routine but low-value preoperative tests for cataract surgery patients associated with cost savings 102

6.49 Apr 12, 2019: Carl Zeiss Meditec reports further growth and defines expectations for fiscal year 2018/19 103

6.50 Apr 12, 2019: Topcon Adds Two New Authorized Dealer Partners 103

6.51 Apr 10, 2019: Eye care devices business Alcon becomes independent entity 103

6.52 Apr 02, 2019: Alcon announces Timothy Stonesifer as Chief Financial Officer 104

6.53 Mar 29, 2019: PolarityTE announces Richard Hague, formerly from Sanofi, Genzyme and recently Anika Therapeutics as Chief Operating Officer 105

6.54 Mar 25, 2019: Ocular Therapeutix names Leslie Williams to board of directors 105

6.55 Mar 18, 2019: Anika Therapeutics names Robert Richard as Vice President of research and development 106

6.56 Mar 07, 2019: Ocular Therapeutix reports fourth quarter and year end 2018 financial results and business update 107

6.57 Mar 01, 2019: Canon Canada appoints Nobuhiko Kitajima as new president and CEO 108

6.58 Feb 27, 2019: Glaukos announces fourth quarter and full year 2018 financial results 108

6.59 Feb 22, 2019: OPHTEC's pre-loaded Capsular Tension Ring (CTR) “Ringject” CFDA approved and soon commercially available in China 110

6.60 Feb 21, 2019: Anika reports fourth quarter and full year 2018 financial results 110

6.61 Feb 21, 2019: STAAR Surgical reports fourth quarter and full year 2018 results 112

6.62 Feb 20, 2019: Bausch Health Companies announces fourth-quarter and full-year 2018 results and provides 2019 guidance 114

6.63 Feb 14, 2019: Volk Optical strengthens investment in India with GM appointment 118

6.64 Feb 11, 2019: Continued profitable growth for Carl Zeiss Meditec in the first three months of 2018/19 119

6.65 Feb 01, 2019: Ziemer Ophthalmic Systems produces 1,000th eye laser 120

6.66 Jan 14, 2019: Carl Zeiss Meditec achieves strong revenue and EBIT growth in first three months 2018/19 121

6.67 Jan 07, 2019: STAAR Surgical Expects Fourth Quarter ICL Sales to Rise 42%; China Units Nearly Double, U.S. Market Returns to Growth 121

6.68 Jan 01, 2019: LIGHTMED founder and executive chairman Gary Lee reassumes CEO role 121

6.69 Jan 01, 2019: LIGHTMED corporation founder and Executive Chairman Gary Lee Reassumes CEO role 122

7 Appendix 123

7.1 Methodology 123

7.2 About GlobalData 126

7.3 Contact Us 126

7.4 Disclaimer 126

List of Tables

Table 1: Cataract Surgery Devices – Pipeline Products by Stage of Development 9

Table 2: Cataract Surgery Devices – Pipeline Products by Segment 10

Table 3: Cataract Surgery Devices – Pipeline Products by Territory 11

Table 4: Cataract Surgery Devices – Pipeline Products by Regulatory Path 12

Table 5: Cataract Surgery Devices – Pipeline Products by Estimated Approval Date 13

Table 6: Cataract Surgery Devices – Ongoing Clinical Trials 14

Table 7: Cataract Surgery Devices Companies – Pipeline Products by Stage of Development 15

Table 8: Cataract Surgery Devices – Pipeline Products by Stage of Development 16

Table 9: Advanced Refractive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 17

Table 12: Altacor Ltd Pipeline Products & Ongoing Clinical Trials Overview 18

Table 15: Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Table 40: Cirle, Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Table 43: Dutch Ophthalmic Research Center International BV Pipeline Products & Ongoing Clinical Trials Overview 27

Table 46: Eye Care and Cure Pipeline Products & Ongoing Clinical Trials Overview 28

Table 49: Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 29

Table 52: Iantech Inc Pipeline Products & Ongoing Clinical Trials Overview 30

Table 55: International BioMedical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 31

Table 58: Medicontur Medical Engineering Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

Table 61: Mynosys Cellular Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33

Table 66: OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview 35

Table 71: Paradigm Medical Industries, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 38

Table 74: Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

Table 77: STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview 40

Table 80: Tear Diagno LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 41

Table 83: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 42

Table 86: University of Florida Pipeline Products & Ongoing Clinical Trials Overview 43

Table 89: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 44

Table 92: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 45

Table 95: VSY Biotechnology BV Pipeline Products & Ongoing Clinical Trials Overview 46

Table 98: Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 47

Table 101: Glossary 125

List of Figures

Figure 1: Cataract Surgery Devices – Pipeline Products by Stage of Development 9

Figure 2: Cataract Surgery Devices – Pipeline Products by Segment 10

Figure 3: Cataract Surgery Devices – Pipeline Products by Territory 11

Figure 4: Cataract Surgery Devices – Pipeline Products by Regulatory Path 12

Figure 5: Cataract Surgery Devices – Pipeline Products by Estimated Approval Date 13

Figure 6: Cataract Surgery Devices – Ongoing Clinical Trials 14

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports